Periodic Fever Syndrome Market Insights Video

According to Cognitive Market Research, the global Periodic Fever Syndrome market size is USD 625.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 5.00% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 250.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 187.68 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 143.89 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.00% from 2024 to 2031.
• Latin America had a market share for more than 5% of the global revenue with a market size of USD 31.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 12.51 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031.
• The Hyperimmunoglobulinemia D Syndrome held the highest Periodic Fever Syndrome market revenue share in 2024.